Clinical Pharmacokinetics and Selective Pharmacodynamics of New Angiotensin Converting Enzyme Inhibitors
- 1 January 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 41 (3), 207-224
- https://doi.org/10.2165/00003088-200241030-00005
Abstract
The angiotensin converting enzyme (ACE) inhibitors are widely used in the management of essential hypertension, stable chronic heart failure, myocardial infarction (MI) and diabetic nephropathy....This publication has 102 references indexed in Scilit:
- FosinoprilClinical Pharmacokinetics, 1997
- Losartan PotassiumDrugs, 1996
- TrandolaprilDrugs, 1994
- Digoxin Pharmacokinetics and Spirapril, a New Ace InhibitorThe Journal of Clinical Pharmacology, 1991
- Clinical Pharmacokinetics of the Newer ACE InhibitorsClinical Pharmacokinetics, 1990
- Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.BMJ, 1988
- Pentopril‐Cimetidine Interaction Caused by a Reduction in Hepatic Blood FlowThe Journal of Clinical Pharmacology, 1988
- Multiple‐dose Cimetidine Administration Does Not Influence the Single‐dose Pharmacokinetics of Quinapril and Its Active Metabolite (CI‐928)The Journal of Clinical Pharmacology, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Clinical Pharmacokinetics of the Angiotensin Converting Enzyme Inhibitors A ReviewClinical Pharmacokinetics, 1985